Literature DB >> 16432095

Assessing the performance of overseas tuberculosis screening programs: a study among US-bound immigrants in Vietnam.

Susan A Maloney1, Katherine L Fielding, Kayla F Laserson, Warren Jones, Thi Ngoc Yen Nguyen, Quy An Dang, Huu Phuoc Nguyen, An Trinh Nguyen, Thi Cam Nhung Duong, Thi Chi Mai Vo, M Frank Seawright, Thomas O'Rourke, Xuan Lien Truong, Thi Ngoc Lan Nguyen, Nancy Binkin, Martin S Cetron.   

Abstract

BACKGROUND: Tuberculosis cases in foreign-born persons account for more than 50% of all tuberculosis cases in the United States. The Institute of Medicine has recommended enhancing overseas screening as one measure to support tuberculosis elimination efforts. We assessed the ability of overseas tuberculosis screening (chest radiograph followed by 3 acid-fast bacilli sputum smears for persons with abnormal chest radiographs [suggestive of active tuberculosis]) to detect pulmonary tuberculosis disease among US-bound immigrants with abnormal chest radiographs.
METHODS: During October 1998 to October 1999, 14 098 US immigrant visa applicants were screened overseas in Vietnam. Adult applicants with abnormal chest radiographs were enrolled to assess screening test characteristics among this group using mycobacterial culture as the gold standard for pulmonary tuberculosis disease diagnosis. Risk factors for pulmonary tuberculosis disease were also evaluated.
RESULTS: Among 1179 adult applicants with abnormal chest radiographs, 82 (7.0%) had positive acid-fast bacilli smear results, and 183 (15.5%) had positive Mycobacterium tuberculosis culture results (pulmonary tuberculosis disease). The sensitivity, specificity, and positive and negative predictive values of serial acid-fast bacilli screening among this group were 34.4% (63/183), 98.1% (977/996), 76.8% (63/82), and 89.1% (977/1097), respectively. Risk factors for pulmonary tuberculosis disease included younger age (18-34 years), no history of tuberculosis or treatment, reported symptoms, and cavitation or consolidation on chest radiograph.
CONCLUSIONS: The ability of current overseas screening to detect tuberculosis among immigrants with abnormal chest radiographs is low. Improved diagnostic methods, enhanced screening measures, and postmigration follow-up are essential to control tuberculosis among immigrants and support US and global tuberculosis elimination.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16432095     DOI: 10.1001/archinte.166.2.234

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  16 in total

1.  Tuberculosis among persons born in the Philippines and living in the United States, 2000-2007.

Authors:  Lilia Ponce Manangan; Catheryn Jumao-as Salibay; Ryan MacLaren Wallace; Steve Kammerer; Robert Pratt; Laura McAllister; Valerie Robison
Journal:  Am J Public Health       Date:  2010-03-18       Impact factor: 9.308

Review 2.  Epidemiology of Tuberculosis in the United States.

Authors:  Adam J Langer; Thomas R Navin; Carla A Winston; Philip LoBue
Journal:  Clin Chest Med       Date:  2019-12       Impact factor: 2.878

3.  Effect of a culture-based screening algorithm on tuberculosis incidence in immigrants and refugees bound for the United States: a population-based cross-sectional study.

Authors:  Yecai Liu; Drew L Posey; Martin S Cetron; John A Painter
Journal:  Ann Intern Med       Date:  2015-03-17       Impact factor: 25.391

4.  Tuberculosis among healthcare workers, United States, 1995-2007.

Authors:  Lauren A Lambert; Robert H Pratt; Lori R Armstrong; Maryam B Haddad
Journal:  Infect Control Hosp Epidemiol       Date:  2012-09-19       Impact factor: 3.254

5.  Persistent latent tuberculosis reactivation risk in United States immigrants.

Authors:  Nicholas D Walter; John Painter; Matthew Parker; Phillip Lowenthal; Jennifer Flood; Yunxin Fu; Redentor Asis; Randall Reves
Journal:  Am J Respir Crit Care Med       Date:  2014-01-01       Impact factor: 21.405

6.  A comparative examination of tuberculosis immigration medical screening programs from selected countries with high immigration and low tuberculosis incidence rates.

Authors:  Gonzalo G Alvarez; Brian Gushulak; Khaled Abu Rumman; Ekkehardt Altpeter; Daniel Chemtob; Paul Douglas; Connie Erkens; Peter Helbling; Ingrid Hamilton; Jane Jones; Alberto Matteelli; Marie-Claire Paty; Drew L Posey; Daniel Sagebiel; Erika Slump; Anders Tegnell; Elena Rodríguez Valín; Brita Askeland Winje; Edward Ellis
Journal:  BMC Infect Dis       Date:  2011-01-04       Impact factor: 3.090

7.  Multidrug-resistant tuberculosis outbreak among US-bound Hmong refugees, Thailand, 2005.

Authors:  John E Oeltmann; Jay K Varma; Luis Ortega; Yecai Liu; Thomas O'Rourke; Maria Cano; Theresa Harrington; Sean Toney; Warren Jones; Samart Karuchit; Lois Diem; Dhanida Rienthong; Jordan W Tappero; Kashef Ijaz; Susan A Maloney
Journal:  Emerg Infect Dis       Date:  2008-11       Impact factor: 6.883

8.  Prevalence of abnormal radiological findings in health care workers with latent tuberculosis infection and correlations with T cell immune response.

Authors:  Rajnish Joshi; Samir Patil; Shriprakash Kalantri; Kevin Schwartzman; Dick Menzies; Madhukar Pai
Journal:  PLoS One       Date:  2007-08-29       Impact factor: 3.240

9.  Implementation of new TB screening requirements for U.S.-bound immigrants and refugees - 2007-2014.

Authors:  Drew L Posey; Mary P Naughton; Erika A Willacy; Michelle Russell; Christine K Olson; Courtney M Godwin; Pamela S McSpadden; Zachary A White; Terry W Comans; Luis S Ortega; Michael Guterbock; Michelle S Weinberg; Martin S Cetron
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-03-21       Impact factor: 17.586

10.  Tuberculin Skin Tests versus Interferon-Gamma Release Assays in Tuberculosis Screening among Immigrant Visa Applicants.

Authors:  Stella O Chuke; Nguyen Thi Ngoc Yen; Kayla F Laserson; Nguyen Huu Phuoc; Nguyen An Trinh; Duong Thi Cam Nhung; Vo Thi Chi Mai; An Dang Qui; Hoang Hoa Hai; Le Thien Huong Loan; Warren G Jones; William C Whitworth; J Jina Shah; John A Painter; Gerald H Mazurek; Susan A Maloney
Journal:  Tuberc Res Treat       Date:  2014-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.